Winton Group LTD Cytosorbents Corp Transaction History

Winton Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$3.61 - $5.22 $92,697 - $134,039	-25,678 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$4.33 - $7.63 $111,185 - $195,923	25,678 New	25,678 $129,000
Q2 2019 Jul 08, 2019	SELL	$5.92 - $7.78 $83,252 - $109,410	-14,063 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$6.82 - $8.56 $95,909 - $120,379	14,063 New	14,063 $106,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.